Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Head & Neck|October 28, 2023
The neutrophil-to-lymphocyte ratio in salivary gland cancers treated with pembrolizumabRex H Lee, Angeline Truong, Xin Wu, et al.
Cancer Immunology Research|December 20, 2019
Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell ResponsesSamantha K Greaney, Alain P Algazi, Katy K Tsai, et al.
Cancer|October 30, 2022
Phase 1/2 study of epacadostat in combination with durvalumab in patients with metastatic solid tumorsAung Naing, Alain P Algazi, Gerald S Falchook, et al.
The Laryngoscope|January 3, 2026
Perineural Invasion and Survival in Pembrolizumab-Treated Head and Neck Squamous Cell CarcinomaAngeline A Truong, Savinnie Ho, Rex H Lee, et al.
Head & Neck|May 10, 2026
Neutrophil-To-Lymphocyte Ratio and Survival in Pembrolizumab-Treated Oropharyngeal CancerAngeline A Truong, Savinnie Ho, Rex H Lee, et al.
The Laryngoscope|March 29, 2019
Treatment modality impact on quality of life for human papillomavirus-associated oropharynx cancerMary Jue Xu, Karolina A Plonowska, Zev R Gurman, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|December 15, 2024
Neutrophil-to-Lymphocyte Ratio and Pembrolizumab Outcomes in Oral Cavity Squamous Cell CarcinomaAngeline A Truong, Rex H Lee, Xin Wu, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|May 22, 2023
A prospective evaluation of neck and shoulder function following treatments of early-stage human papillomavirus-associated oropharynx cancerArushi Gulati, Karolina Plonowska-Hirschfeld, Erika M Stephens, et al.
Pageof 5